Finding Candida yeast in a urine culture is surprisingly common in hospitalized patients and does not always mean you have an infection that needs treatment. In one large analysis of over 111,000 urine cultures, Candida species showed up in about 2.7% of samples, with Candida albicans accounting for roughly half of those isolates. The tricky part is figuring out whether the yeast is just passing through, harmlessly colonizing the urinary tract, or actively causing disease. That distinction drives every decision about whether and how to treat.
Why Candida Ends Up in Urine
Candida is a normal resident of the human body. It lives on skin, in the gut, and in the genital tract without causing problems for most people. It gets into the urinary system through a few routes. The most straightforward is ascending infection: yeast from the perineal or genital area travels up the urethra into the bladder, much the way bacteria cause a typical urinary tract infection. In hospitalized patients, a urinary catheter provides a direct highway. Once a catheter is in place, Candida can stick to the device surface and build a biofilm, a slimy layer of yeast cells embedded in a protective matrix that makes the organism harder for the immune system or antifungal drugs to reach.1PubMed Central. Rat indwelling urinary catheter model of Candida albicans biofilm infection Research has shown that in a catheterized bladder, proteins deposited on the catheter surface, particularly fibrinogen, help Candida attach and form these biofilms.2PubMed Central. The catheterized bladder environment promotes Efg1- and Als1-dependent Candida albicans infection
Less commonly, Candida reaches the kidneys from the bloodstream. If someone has candidemia (Candida circulating in the blood), the yeast can seed the kidneys and then appear in the urine. This route is more dangerous because it signals widespread infection, not just a local urinary problem.
Who Is Most at Risk
Candiduria clusters around a well-recognized set of risk factors. The major ones are diabetes, indwelling urinary catheters, recent use of broad-spectrum antibiotics, urinary obstruction, and admission to an intensive care unit.3PubMed. Candida urinary tract infections in adults These factors often overlap. A diabetic patient in the ICU with a catheter and a course of antibiotics on board has multiple things working against them at once.
Diabetes deserves special attention. Elevated blood sugar spills glucose into the urine, and that sugar-rich environment is essentially a feast for yeast. A study of elderly diabetic patients found a strong positive correlation between the degree of glucose in the urine and the number of Candida colonies growing in urine cultures. The more glucose present, the higher the colony counts.4Medicra (Journal of Medical Laboratory Science/Technology). Relationship of Candida albicans Urinary Colony Count and Glucosuria in Elderly Diabetics
Antibiotics contribute in a different way. Broad-spectrum antibiotics wipe out the normal bacteria that keep Candida in check. Once that bacterial competition is gone, yeast can move in and establish itself.5Urogenital Tract Infection. Management of Candida Urinary Tract Infection in the Elderly This is why candiduria often appears after days or weeks of antibiotic treatment for a bacterial infection.
Which Candida Species Show Up
Candida albicans has historically been the dominant species found in urine, but the landscape has been shifting. In a large study of over 3,000 urinary Candida isolates, C. albicans made up about 54%, followed by Nakaseomyces glabrata (formerly called Candida glabrata) at roughly 23% and Candida tropicalis at about 10%.6PubMed Central. Microbiological Relevance of Candida in Urine Cultures Other studies from different regions report somewhat different proportions. A molecular identification study from Honduras, for instance, found C. albicans and C. glabrata nearly tied at about 30% and 29% of isolates, respectively.7Revista Iberoamericana de MicologÃa. Molecular identification of Candida species from urinary infections in Honduras
The species matters because it affects treatment. Most C. albicans isolates remain susceptible to fluconazole, the go-to antifungal for urinary tract Candida infections. One analysis found that about 94% of C. albicans isolates were susceptible to fluconazole, compared to only about 73% of non-albicans species.8PubMed Central. Candida growth in urine cultures: a contemporary analysis of species and antifungal susceptibility profiles C. glabrata in particular has inherently reduced susceptibility to fluconazole, and C. krusei is considered intrinsically resistant. As non-albicans species become more common, treatment decisions get more complicated, and susceptibility testing becomes more important.
Symptoms and How to Recognize an Actual Infection
Here is where things get genuinely confusing, for patients and doctors alike. Many people with Candida in their urine have no symptoms at all. The yeast is just there, colonizing the bladder surface or passing through without causing inflammation. Asymptomatic candiduria is especially common in catheterized patients and is not, by itself, a reason to treat.
When Candida does cause a true urinary tract infection, the symptoms can look a lot like a bacterial UTI: burning during urination, frequent urges to urinate, lower abdominal or pelvic discomfort, and cloudy or foul-smelling urine. If the infection involves the kidneys (a condition sometimes called ascending pyelonephritis), you might also have flank pain, fever, and general malaise. In critically ill patients, the signs can be subtler or masked by other conditions, making the diagnosis harder.
One of the biggest diagnostic headaches is that there is no agreed-upon colony count threshold that reliably separates colonization from infection. With bacterial UTIs, labs typically use a cutoff of 100,000 colony-forming units per milliliter to define a “positive” culture. For Candida, no such standard exists. The absence of clear thresholds, combined with inconsistent lab workflows, means that two hospitals might interpret the same culture result differently.9PubMed Central. Catheter-Associated Candiduria: Aggregates, Microscopy, and CFU Variability Doctors end up relying on the full clinical picture: Is the patient symptomatic? Are there risk factors? Does the yeast keep showing up in repeat cultures?
The Overtreatment Problem
Because candiduria is so common in hospitalized patients and because it can be hard to distinguish from a true infection, overtreatment is a real and well-documented problem. Clinical guidelines are clear that asymptomatic candiduria generally should not be treated with antifungal drugs. The recommended approach is to address the underlying factors: remove or replace the catheter, improve blood sugar control, discontinue unnecessary antibiotics.10PubMed Central. Overtreatment of Asymptomatic Candiduria among Hospitalized Patients: a Multi-institutional Study In many cases, the candiduria resolves on its own once those predisposing conditions are corrected.
Despite this guidance, a multi-institutional study found that antifungals are frequently prescribed for patients whose candiduria does not warrant treatment. Unnecessary antifungal use is not harmless. It exposes patients to side effects, drives up drug-resistant Candida strains, and adds cost. The exceptions where asymptomatic candiduria does deserve treatment include patients who are about to undergo urinary tract surgery (where yeast in the tract could seed a surgical-site infection) and certain high-risk groups like neutropenic patients.
Treatment When It Is Warranted
When a patient has symptomatic candidal UTI or meets criteria for treatment, fluconazole is the first-line drug. It reaches high concentrations in urine, comes in both oral and intravenous forms, and has a favorable safety profile.11Clinical Infectious Diseases. Candida Urinary Tract Infections—Treatment Most treatment courses run about two weeks for bladder infections, though duration varies depending on severity and the patient’s immune status.
Echinocandins, another class of antifungals that work well against Candida in the bloodstream, are less useful for urinary infections because they barely show up in the urine. The same limitation applies to some of the newer azole antifungals. This pharmacologic quirk means the treatment options for urinary Candida are more limited than for Candida infections elsewhere in the body.
For catheter-associated candiduria that is not resolving, bladder irrigation with amphotericin B is another option. A meta-analysis found that amphotericin B bladder irrigation was more effective than oral fluconazole for clearing fungal urinary tract infections and was associated with fewer side effects, though the authors cautioned that the included studies were small.12PubMed Central. Effect of bladder irrigation with amphotericin B for treatment of urinary tract fungal infection: a meta-analysis The concentration of amphotericin B in the irrigation fluid matters: a randomized trial comparing 10 mg/L to 50 mg/L found that the higher concentration achieved 100% eradication, while the lower concentration cleared the infection only two-thirds of the time. The trial was actually stopped early because all the failures were happening in the lower-dose group.13PubMed. Comparison of two concentrations of amphotericin B bladder irrigation in the treatment of funguria in patients with indwelling urinary catheters Research has also shown that a two-day irrigation protocol can be as effective as a five-day course, which saves time and reduces cost.14PubMed. Clearance of Candida colonizing the urinary bladder by a two-day amphotericin B irrigation
Complications Worth Knowing About
Most candiduria, especially when promptly managed, does not lead to serious complications. But when it does go wrong, it can go very wrong. One of the more dramatic complications is the formation of fungal balls. These are clumps of yeast, dead tissue, and debris that can form in the renal pelvis or ureters. On ultrasound, a fungal ball typically appears as a mobile, bright mass inside the kidney’s collecting system.15PubMed Central. Renal fungal ball—two case reports and review of literature On CT, it shows up as an oval, well-defined mass that is not attached to the wall of the ureter or kidney.16PubMed. Renal fungal ball: an unusual sonographic finding If a fungal ball blocks the ureter, it can cause hydronephrosis (swelling of the kidney from backed-up urine) and may require surgical drainage.
The more feared complication is progression to invasive candidiasis. If Candida enters the bloodstream from the urinary tract, it can seed other organs. Candida species are the fourth most common bloodstream isolates in US hospitals, and they account for roughly 5% of all cases of severe sepsis and septic shock. About a third of candidemia episodes occur in ICU settings, and delays in starting appropriate antifungal treatment are associated with higher mortality.17PubMed Central. Invasive candidiasis as a cause of sepsis in the critically ill patient This is why candiduria in a critically ill patient, even if seemingly uncomplicated, deserves close monitoring.
Candiduria in Newborns and Infants
Candida in the urine of a newborn is a very different situation than in an adult. In neonatal intensive care units, Candida is a common cause of urinary tract infection, and it carries a much higher risk of serious consequences. A multicenter Canadian study of 30 infants with candiduria found that renal ultrasound showed findings consistent with possible fungal disease in more than half the cases. Four of the 30 infants developed extra-renal candidiasis, meaning the infection had spread beyond the kidneys. The overall mortality rate in the study was 30%, and Candida infection was considered a contributing factor in a third of the deaths.18PubMed Central. Characteristics and outcome of infants with candiduria in neonatal intensive care – a Paediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study
In neonates, candiduria is frequently associated with candidemia, which is why systemic antifungal therapy is generally warranted rather than a watch-and-wait approach. Amphotericin B has traditionally been the drug of choice for neonates with renal candidiasis.19PubMed. Candidal renal and urinary tract infection in neonates Fungal balls in neonatal kidneys can persist on ultrasound long after the infection has clinically resolved, so their sonographic appearance alone should not drive the decision to keep extending antifungal therapy.
Prematurity is one of the strongest risk factors for candiduria in neonates, while in older infants and children, urinary catheterization and prior bacterial UTI are the dominant risk factors. A large study of critically ill pediatric patients across age groups found that all patients who received empirical treatment with fluconazole or amphotericin B achieved complete clinical and microbiological resolution, supporting fluconazole as a reasonable first-line choice in this population too.20PubMed Central. Symptomatic candiduria in neonates, infants, and pediatric patients admitted to ICUs: epidemiology, risk factors, clinical symptoms, and outcomes of empirical antifungal therapy
Candiduria During Pregnancy
Pregnant women are more susceptible to yeast infections generally, including vaginal candidiasis, due to hormonal changes that alter the vaginal environment. Candida can appear in urine cultures during pregnancy, and the question of how to treat it requires some caution around drug safety. Oral fluconazole, particularly at high doses or in the first trimester, has been associated with potential risks in some studies, so topical azole antifungals are the recommended treatment for vaginal yeast infections during pregnancy, typically for at least seven days to ensure adequate effectiveness.21PubMed Central. Vaginal yeast infections during pregnancy For a true urinary Candida infection during pregnancy, treatment decisions should involve weighing the severity of the infection against the safety profiles of available antifungals, and this is a conversation to have with an obstetrician or infectious disease specialist rather than to manage independently.
Drug Resistance and Shifting Species
One trend worth watching is the growing proportion of non-albicans Candida species in urinary isolates. This shift matters because non-albicans species are more likely to be resistant to fluconazole, and some are intrinsically resistant, meaning fluconazole never worked against them to begin with. C. glabrata in particular has become increasingly common and often requires alternative antifungals like amphotericin B or, in some cases, flucytosine.
The rise in antifungal-resistant strains mirrors what has happened with antibiotic-resistant bacteria: widespread use of antifungal drugs has selected for organisms that can survive them. Urinary tract candidiasis is the most common nosocomial (hospital-acquired) fungal infection worldwide, and that frequency of exposure creates selection pressure.22PubMed Central. Urinary tract infections and Candida albicans This is one more reason why treating asymptomatic candiduria with antifungals, when the guidelines say not to, carries consequences beyond the individual patient. Each unnecessary prescription contributes to a broader resistance problem.
Susceptibility testing, where the lab checks which antifungals a particular isolate responds to, is becoming more important as the species distribution shifts. If you are told you have Candida in your urine and treatment is recommended, it is reasonable to ask whether the specific species has been identified and whether susceptibility results are available. That information can mean the difference between a drug that works and weeks of ineffective therapy.